Showing results (851-860 of 871) with videos related to

Sort By:
Pageof 88
Current Drug Discovery Technologies|March 14, 2026
A Recent Trend in Diagnosis and Therapeutics for Polycystic Ovarian Syndrome (PCOS) Management: A Patent Landscape ReportManinder Singh, Reema Mediratta, Snehanjali Sahoo, et al.
Current Drug Discovery Technologies|March 1, 2026
Revolutionizing Drug Discovery: Modern Advancements in Quality by Design, PAT Tools, and Green ChemistrySoumyashree Tripathy, Suryakanta Swain, Bikash Ranjan Jena, et al.
Current Drug Discovery Technologies|June 4, 2025
Pharmacological Insights on USFDA-approved Novel Drug Therapies in the Year 2023Parveen Kumar Goyal, Vipasha Sharma, Kavita Sangwan
Current Drug Discovery Technologies|June 3, 2025
Breaking Boundaries in Cancer Therapy: Harnessing Chromothripsisinduced Mutations for Targeted Bcl-2 Protein DestabilizationSergey Shityakov, Michael Nosonovsky, Ekaterina V Skorb, et al.
Current Drug Discovery Technologies|March 1, 2026
GABA Promoter and PDE4 Inhibitor in the Management of Polycystic Ovary Syndrome: A Nutraceutical ApproachDivyanshi Gupta, Lucy Mohapatra, Ankita Wal
Current Drug Discovery Technologies|March 21, 2026
Progress in Monoclonal Antibodies: From Lab Innovations to Life-Saving TherapiesTejaswini P Masne, Kalyani R Thombre, Krishna R Gupta, et al.
Current Drug Discovery Technologies|May 21, 2026
Fused 1H-/2H-Indazole as Bioactive Privileged Scaffolds: Synthetic Strategies and Pharmaceutical ApplicationsRicha Sharma, Amol T Mahajan, Vidit Shrivastava, et al.
Current Drug Discovery Technologies|May 21, 2026
Evolving Global Regulatory Frameworks for Drug Discovery and Development: Harmonization and Future DirectionsVirendra S Gomase, Rupali Sharma, Suchita P Dhamane, et al.
Current Drug Discovery Technologies|March 26, 2013
Network medicine and high throughput screeningRobert E Smith, Kevin Tran, Ralph H Vocque
Current Drug Discovery Technologies|June 18, 2026
Effects of Ganoderma lucidum Polysaccharide Peptide on Inflammatory and Metabolic Biomarkers in Obese Patients with Cardiometabolic Syndrome: A Randomized Controlled TrialNuril Farid Abshori, Syanindita Wardhani, Fatahillah Fatoni, et al.
Pageof 88